ID

13475

Description

Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Keywords

Versions (5)
  1. 3/5/15 3/5/15 -
  2. 3/9/15 3/9/15 -
  3. 4/24/15 4/24/15 -
  4. 12/15/15 12/15/15 -
  5. 2/11/16 2/11/16 -
Uploaded on

February 11, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

End of Study AMLSG 21-13 DRKS00007189 NCT02013648 Akute myeloische Leukämie (AML)

English

End of Study AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

1 forms  
End of Study
Description

End of Study

End of Study Date
Description

End of Study Date

Data type

date

Alias
UMLS CUI-1
C2983670
Reason for End of Study
Description

Reason for End of Study

Data type

integer

Alias
UMLS CUI-1
C2348577
Specify if Reason for End of Study = 6 or 7
Description

Specify if Reason for End of Study = 6 or 7

Data type

text

Alias
UMLS CUI [1]
C1521902
Induction therapy I administered
Description

Induction therapy I administered

Data type

boolean

Alias
UMLS CUI [1,1]
C3179010
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205447
Induction therapy II administered
Description

Induction therapy II administered

Data type

boolean

Alias
UMLS CUI [1,1]
C3179010
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205448
Consolidation therapy I administered
Description

Consolidation therapy I administered

Data type

boolean

Alias
UMLS CUI [1,1]
C3179017
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205447
Consolidation therapy II administered
Description

Consolidation therapy II administered

Data type

boolean

Alias
UMLS CUI [1,1]
C3179017
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205448
Consolidation therapy III administered
Description

Consolidation therapy III administered

Data type

boolean

Alias
UMLS CUI [1,1]
C3179017
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205449
Consolidation therapy IV administered
Description

Consolidation therapy IV administered

Data type

boolean

Alias
UMLS CUI [1,1]
C3179017
UMLS CUI [1,2]
C0806914
UMLS CUI [1,3]
C0205450
Maintenance therapy administered
Description

Maintenance therapy administered

Data type

boolean

Alias
UMLS CUI [1,1]
C0481504
UMLS CUI [1,2]
C0806914
Signature
Description

Signature

Date
Description

Date

Data type

date

Alias
UMLS CUI-1
C0011008
Name of Investigator
Description

Name of Investigator

Data type

text

Alias
UMLS CUI-1
C2826892
Signature of investigator
Description

Signature of investigator

Data type

text

Alias
UMLS CUI-1
C2346576
Back to the top of the page

Similar models

End of Study AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
End of Study
End of Study Date
Item
End of Study Date
date
C2983670 (UMLS CUI-1)
Item
Reason for End of Study
integer
C2348577 (UMLS CUI-1)
Reason for End of Study
Code List
Reason for End of Study
CL Item
regular End of Study (0)
C0205272 (UMLS CUI-1)
CL Item
no CR after Induction (Progressive Disease) (1)
C1335499 (UMLS CUI-1)
CL Item
exzessive extramedullary medical toxicity (2)
C0013221 (UMLS CUI-1)
CL Item
death (3)
C0021430 (UMLS CUI-1)
CL Item
relapse after CR (4)
C0035020 (UMLS CUI-1)
CL Item
Withdrawal of informed consent (5)
C0021430 (UMLS CUI-1)
C1710677 (UMLS CUI-2)
CL Item
Protocol deviation (6)
C1705236 (UMLS CUI-1)
CL Item
other (7)
C0205394 (UMLS CUI-1)
Specify if Reason for End of Study = 6 or 7
Item
Specify if Reason for End of Study = 6 or 7
text
C1521902 (UMLS CUI [1])
Induction therapy I administered
Item
Induction therapy I administered
boolean
C3179010 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205447 (UMLS CUI [1,3])
Induction therapy II administered
Item
Induction therapy II administered
boolean
C3179010 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205448 (UMLS CUI [1,3])
Consolidation therapy I administered
Item
Consolidation therapy I administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205447 (UMLS CUI [1,3])
Consolidation therapy II administered
Item
Consolidation therapy II administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205448 (UMLS CUI [1,3])
Consolidation therapy III administered
Item
Consolidation therapy III administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205449 (UMLS CUI [1,3])
Consolidation therapy IV administered
Item
Consolidation therapy IV administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205450 (UMLS CUI [1,3])
Maintenance therapy administered
Item
Maintenance therapy administered
boolean
C0481504 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
Item Group
Signature
Date
Item
Date
date
C0011008 (UMLS CUI-1)
Name of Investigator
Item
Name of Investigator
text
C2826892 (UMLS CUI-1)
Signature of investigator
Item
Signature of investigator
text
C2346576 (UMLS CUI-1)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial